Two MIT research groups have designed biological molecules that could help combat the effects of covid-19.
One team, led by principal research scientist Shuguang Zhang and research scientist Rui Qing, developed proteins that could be injected into the body to block “cytokine storms,” immune-system overreactions that damage the lungs and can be fatal. The proteins, lab-modified versions of naturally occurring cytokine receptors, could bind to excess cytokines and remove them from the system, says Qing. Tests in human cells and animal models are planned.
The other team, led by associate professor of chemistry Brad Pentelute, designed a short protein fragment, or peptide, that can bind to the viral protein used to enter human lung cells, potentially disarming it. The peptide mimics a cell surface protein that attaches to one of the protein spikes protruding from the coronavirus. The researchers have sent samples to collaborators who plan to carry out tests in human cells.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.